Read press release BRCA 1/2 gene mutations - A to Z
This page links to content about the BRCA1 and BRCA2 genes.
Inheriting a fault (mutation) in one of these genes greatly increases a woman’s risk of breast cancer. Although rare, the BRCA genes are also linked to an increased risk of prostate and ovarian cancer.
Find out more using the links below.
Browse content about BRCA 1/2 gene mutations
Latest BRCA 1/2 gene mutations news from Cancer Research UK
- News story: Israeli researchers developing BRCA 'radiation' test
22 January 2013 - News story: 'Targeted' breast and ovarian cancer drug could have far wider application
23 August 2011 - Press Release: Scientists discover first DNA region to alter breast cancer risk in women with BRCA1 faults
19 September 2010 - News story: Men with faulty BRCA2 gene have estimated 1-in-15 chance of breast cancer by age 70
8 July 2010 - News story: Promising early results from drug trial for inherited ovarian cancer
20 April 2010 - News story: New drugs could treat more types of cancer
17 September 2009 - Press Release: Cauliflower and broccoli boost cancer protection
7 February 2006
- Press Release: Hundreds more breast cancer patients should be tested for BRCA1 gene
15 February 2012 - News story: Trial suggests PARP inhibitor drugs may help to prevent ovarian cancer from coming back
19 May 2011 - News story: Experimental drug shrinks tumours in women with hereditary breast and ovarian cancers
16 August 2010 - Press Release: Gene study backs promise of breast cancer drugs to treat hereditary prostate cancer
24 June 2010 - News story: Lifetime Achievement Award for Professor Alan Ashworth
30 September 2009 - News story: Fertility authority may allow cancer screening
11 May 2006
Rated 5 out of 5 based on 2 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Increase text size
Decrease text size
Print page
Fast fact
In the 1990s, Cancer Research UK scientists played a fundamental role in the discovery of BRCA1 and BRCA2.
